Skip to content
healthcare.dev

Everolimus

NDC 51991-992, Everolimus, tablet, for suspension, from Breckenridge Pharmaceutical, Inc..

Product NDC
51991-992
Status
Listed
Labeler
Breckenridge Pharmaceutical, Inc.
Dosage form
TABLET, FOR SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA217640
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/51991-992 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • EVEROLIMUS5 mg/1

Pharmacologic classes

Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; Decreased Immunologic Activity [PE]; Kinase Inhibitor [EPC]; Protein Kinase Inhibitors [MoA]; mTOR Inhibitor Immunosuppressant [EPC]; mTOR Inhibitors [MoA]

Package NDCNDC-11Package
51991-992-28519910992284 BLISTER PACK in 1 CARTON (51991-992-28) / 7 TABLET, FOR SUSPENSION in 1 BLISTER PACK (51991-992-99)
51991-992-775199109927728 TABLET, FOR SUSPENSION in 1 BOTTLE (51991-992-77)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/01f7b5fb-be0d-4adf-acd2-6899018de966

Use it

Look up 51991-992 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/51991-992 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 51991-992. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.